Clinical trial
Testosterone Replacement in Older Men and Atherosclerosis Progression
NCT00287586 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00287586 |
|---|---|
| Title | Testosterone Replacement in Older Men and Atherosclerosis Progression |
| Official title | Effects of Testosterone Replacement on Atherosclerosis Progression in Older Men With Low Testosterone Levels |
| Acronym | TEAAM |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Collaborators | Solvay Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypogonadism, Atherosclerosis |
| Intervention type | Drug |
| Interventions | Testosterone Gel (Androgel), Placebo |
| Enrollment | 308 |
| Start date | Sep 1, 2004 |
| Primary completion | Feb 7, 2012 |
| Completion | May 12, 2012 |
| First posted | Feb 7, 2006 |
| Last update posted | Jun 29, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: